EV/EBITDA:
-7.08-0.07(-1.00%)Summary
- As of today, ELVN EV/EBITDA is -7.08, with a fall of -0.07 (-1.00%) during the current trading session.
- Over the past year, ELVN EV/EBITDA has increased by +2.41 (+25.40%).
- ELVN EV/EBITDA is now -325.48% below its all-time high of 3.14.
Performance
ELVN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ELVN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -1.0% | +0.9% | +0.6% |
| 1M1 Month | -1.9% | +1.8% | +1.0% |
| 3M3 Months | -17.8% | +15.7% | +7.8% |
| 6M6 Months | -43.6% | +46.4% | +26.4% |
| YTDYTD | +6.3% | +0.6% | -4.9% |
| 1Y1 Year | +25.4% | -16.6% | -15.8% |
| 5Y5 Years | -3178.3% | +10000.0% | +4.4% |
ELVN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -5.08 | -39.4% | -8.42 | +15.9% |
| 3M | 3-Month | -5.08 | -39.4% | -8.42 | +15.9% |
| 6M | 6-Month | -4.51 | -57.0% | -9.76 | +27.5% |
| 1Y | 1-Year | -4.02 | -76.1% | -9.76 | +27.5% |
| 3Y | 3-Year | 1.96 | -461.2% | -28.20 | +74.9% |
| 5Y | 5-Year | 1.96 | -461.2% | -28.20 | +74.9% |
| All-Time | All-Time | 3.14 | -325.5% | -28.20 | +74.9% |
ELVN EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.08(+6.3%) |
| 2024 | -7.56(-97.4%) |
| 2023 | -3.83(-298.4%) |
| Date | Value |
|---|---|
| 2022 | 1.93(+32.2%) |
| 2021 | 1.46(+830.0%) |
| 2020 | -0.20 |
FAQ
- What is Enliven Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Enliven Therapeutics, Inc.?
- What is ELVN EV/EBITDA year-to-date change?
- What is Enliven Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Enliven Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of ELVN is -7.08
What is the all-time high EV/EBITDA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high EV/EBITDA is 3.14
What is ELVN EV/EBITDA year-to-date change?
Enliven Therapeutics, Inc. EV/EBITDA has changed by +0.48 (+6.35%) since the beginning of the year
What is Enliven Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, ELVN EV/EBITDA has changed by +2.41 (+25.40%)